4//SEC Filing
Stehman-Breen Catherine 4
Accession 0000950170-25-081353
CIK 0001818794other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 9:37 PM ET
Size
15.6 KB
Accession
0000950170-25-081353
Insider Transaction Report
Form 4
Stehman-Breen Catherine
Director
Transactions
- Award
Stock option (right to buy)
2025-05-30+35,000→ 35,000 totalExercise: $11.96Exp: 2035-05-29→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This option was granted on May 30, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 30, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
Related Parties
1- filerCIK 0001702233
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 9:37 PM ET
- Size
- 15.6 KB